Astoria Portfolio Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Astoria Portfolio Advisors's ABBV Position: Q2 2026 in Review
Astoria Portfolio Advisors increased its AbbVie (ABBV) stake by 111% in Q2 2026, buying an estimated $1.24M and bringing the position to 10,976 shares worth $2.76M. The position accounts for 0.47% of the portfolio, ranked #35.
Astoria Portfolio Advisors first reported a position in ABBV in Q4 2021 and has held it in 19 quarters since. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Astoria Portfolio Advisors held 10,976 shares of AbbVie worth $2.76M as of Q2 2026.
- Astoria Portfolio Advisors bought 5,773 AbbVie shares in Q2 2026, an estimated $1.24M.
- AbbVie made up 0.47% of Astoria Portfolio Advisors's portfolio in Q2 2026, its #35 holding.
- Astoria Portfolio Advisors first reported a position in AbbVie in Q4 2021 and has held it in 19 quarters since.
- 4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Astoria Portfolio Advisors's 13F filing for Q2 2026, filed 28 Jul 2026.